We observed that systemic injections of the neutralizing anti-PD-L1 antibody alone were unable to control the growth of the weakly immunogenic B16-F10 melanoma (Fig. 4j, k), as reported in previous studies32. The gene discussed is CD274; the disease is melanoma.